aluminium oxide
Aluminium oxide (or aluminium(III) oxide) is a chemical compound of aluminium and oxygen with the chemical formula Al2O3. It is the most commonly occurring of several aluminium oxides, and specifically identified as aluminium oxide. It is commonly called alumina and may also be called aloxide, aloxite, ALOX or alundum in various forms and applications and alumina is refined from bauxite. It occurs naturally in its crystalline polymorphic phase α-Al2O3 as the mineral corundum, varieties of which form the precious gemstones ruby and sapphire,which have an alumina content approaching 100%. Al2O3 is used as feedstock to produce aluminium metal, as an abrasive owing to its hardness, and as a refractory material owing to its high melting point. — Wikipedia
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Earliest trial started Sep 1, 2013 (NCT02511535)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
SMILES
[O-2].[O-2].[O-2].[Al+3].[Al+3]- Mol. weight
- 108.01 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaAluminium oxide ↗
- ChEMBLCHEMBL4594252 ↗
- ChEMBLCHEMBL3707210 ↗
Also known as
- aluminium oxide
- aluminium oxide
- aluminium oxide
- aluminium oxide
- aluminium oxide
- aluminum oxide
- aluminum oxide
- aluminum oxide
- aluminum oxide
- alum ox
- brasivol 1
- brasivol 2
- brasivol 3
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02511535 | Phase 4 | Sep 1, 2013 | University of Vienna |
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Vienna | Academic/Hospital | 1 | 1 | 1 | 2013 |